Patients with FGF23-related hypophosphatemic rickets/osteomalacia do not present with left ventricular hypertrophy
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Patients with FGF23-related hypophosphatemic rickets/osteomalacia do not present with left ventricular hypertrophy
Authors
Keywords
-
Journal
ENDOCRINE RESEARCH
Volume 42, Issue 2, Pages 132-137
Publisher
Informa UK Limited
Online
2016-10-19
DOI
10.1080/07435800.2016.1242604
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy
- (2015) Alexander Grabner et al. Cell Metabolism
- Phosphate enhances Fgf23 expression through reactive oxygen species in UMR-106 cells
- (2015) Michiko Hori et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli
- (2015) Nobuaki Ito et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease
- (2015) Maren Leifheit-Nestler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Elevation of circulating but not myocardial FGF23 in human acute decompensated heart failure
- (2015) Ingrid A. Andersen et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Relationship of FGF23 to indexed left ventricular mass in children with non-dialysis stages of chronic kidney disease
- (2015) Manish D. Sinha et al. PEDIATRIC NEPHROLOGY
- Fibroblast Growth Factor–23 and Cardiac Structure and Function
- (2014) Isha Agarwal et al. Journal of the American Heart Association
- Fibroblast growth factor 23, left ventricular mass, and left ventricular hypertrophy in community-dwelling older adults
- (2013) Anna Jovanovich et al. ATHEROSCLEROSIS
- Fibroblast Growth Factor 23 and Left Ventricular Mass Index in Maintenance Hemodialysis Patients: Standard Versus Long Nocturnal Hemodialysis
- (2013) Bojan Knap et al. THERAPEUTIC APHERESIS AND DIALYSIS
- FGF23 neutralization improves chronic kidney disease–associated hyperparathyroidism yet increases mortality
- (2012) Victoria Shalhoub et al. JOURNAL OF CLINICAL INVESTIGATION
- Relationship of Fibroblast Growth Factor 23 with Left Ventricle Mass Index and Coronary Calcificaton in Chronic Renal Disease
- (2012) Abdulkadir Unsal et al. KIDNEY & BLOOD PRESSURE RESEARCH
- A patient with hypophosphatemic rickets and ossification of posterior longitudinal ligament caused by a novel homozygous mutation in ENPP1 gene
- (2011) Tasuku Saito et al. BONE
- Vitamin D
- (2011) Yaakov Liss et al. Cardiology in Review
- Vitamin D Therapy and Cardiovascular Health
- (2011) Suzanne E. Judd et al. CURRENT HYPERTENSION REPORTS
- The phosphatonin fibroblast growth factor 23 links calcium–phosphate metabolism with left-ventricular dysfunction and atrial fibrillation
- (2011) Sarah Seiler et al. EUROPEAN HEART JOURNAL
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
- (2011) Tamara Isakova et al. KIDNEY INTERNATIONAL
- Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population
- (2009) Majd A.I. Mirza et al. ATHEROSCLEROSIS
- Cornell Product Left Ventricular Hypertrophy in Electrocardiogram and the Risk of Stroke in a General Population
- (2008) Joji Ishikawa et al. HYPERTENSION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now